93 related articles for article (PubMed ID: 27045084)
1. MEK1/2 inhibitors induce interleukin-5 expression in mouse macrophages and lymphocytes.
Li X; Cao X; Zhang X; Kang Y; Zhang W; Yu M; Ma C; Han J; Duan Y; Chen Y
Biochem Biophys Res Commun; 2016 May; 473(4):939-946. PubMed ID: 27045084
[TBL] [Abstract][Full Text] [Related]
2. MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-An anti-atherogenic function of ERK1/2 inhibition.
Zhang L; Chen Y; Yang X; Yang J; Cao X; Li X; Li L; Miao QR; Hajjar DP; Duan Y; Han J
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1180-1191. PubMed ID: 27365310
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.
Ma X; Wang Q; Liu Y; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao RQ; Duan Y; Han J
Int J Cancer; 2015 Feb; 136(4):771-83. PubMed ID: 24947959
[TBL] [Abstract][Full Text] [Related]
4. MEK1/2 inhibitors induce class I alcohol dehydrogenase (ADH1) expression by regulating farnesoid X receptor in hepatic cell lines and C57BL/6J mouse.
Wang X; Yang Y; Chen Y; Duan Y; Han J; Yang X
Mol Biol Rep; 2022 Jul; 49(7):5843-5852. PubMed ID: 35338439
[TBL] [Abstract][Full Text] [Related]
5. Off-target effects of MEK inhibitors.
Wauson EM; Guerra ML; Barylko B; Albanesi JP; Cobb MH
Biochemistry; 2013 Aug; 52(31):5164-6. PubMed ID: 23848362
[TBL] [Abstract][Full Text] [Related]
6. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells.
Smutny T; Bitman M; Urban M; Dubecka M; Vrzal R; Dvorak Z; Pavek P
Arch Toxicol; 2014 Dec; 88(12):2243-59. PubMed ID: 24819614
[TBL] [Abstract][Full Text] [Related]
7. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
Henderson YC; Fredrick MJ; Clayman GL
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):810-5. PubMed ID: 17709622
[TBL] [Abstract][Full Text] [Related]
8. The protease Omi cleaves the mitogen-activated protein kinase kinase MEK1 to inhibit microglial activation.
Hu Q; Li B; Xu R; Chen D; Mu C; Fei E; Wang G
Sci Signal; 2012 Aug; 5(238):ra61. PubMed ID: 22912494
[TBL] [Abstract][Full Text] [Related]
9. Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes.
Wu X; Dayanand KK; Thylur RP; Norbury CC; Gowda DC
J Biol Chem; 2017 Aug; 292(33):13615-13634. PubMed ID: 28679535
[TBL] [Abstract][Full Text] [Related]
10. CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes.
Uchi H; Koga T; Urabe K; Moroi Y; Furue M
J Invest Dermatol; 2003 Jun; 120(6):983-9. PubMed ID: 12787125
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of extracellular signal-regulated kinase 1/2 augments nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophage cells.
Koide N; Ito H; Mu MM; Sugiyama T; Hassan F; Islam S; Mori I; Yoshida T; Yokochi T
FEMS Immunol Med Microbiol; 2005 Aug; 45(2):213-9. PubMed ID: 16051071
[TBL] [Abstract][Full Text] [Related]
12. MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling.
Yang L; Ding JL
Front Immunol; 2019; 10():2020. PubMed ID: 31507609
[TBL] [Abstract][Full Text] [Related]
13. MEK1/2 Inhibition Promotes Macrophage Reparative Properties.
Long ME; Eddy WE; Gong KQ; Lovelace-Macon LL; McMahan RS; Charron J; Liles WC; Manicone AM
J Immunol; 2017 Jan; 198(2):862-872. PubMed ID: 28003382
[TBL] [Abstract][Full Text] [Related]
14. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
J Pharmacol Exp Ther; 2009 Jun; 329(3):856-64. PubMed ID: 19286921
[TBL] [Abstract][Full Text] [Related]
15. Involvement of P2X(7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts.
Montreekachon P; Chotjumlong P; Bolscher JG; Nazmi K; Reutrakul V; Krisanaprakornkit S
J Periodontal Res; 2011 Jun; 46(3):327-37. PubMed ID: 21338358
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17.
Kiga M; Tanzawa F; Iwasaki S; Inaba F; Fujiwara K; Iwadare H; Echigo T; Nakamura Y; Shibata T; Suzuki K; Yasumatsu I; Nakayama A; Sasazawa Y; Tashiro E; Imoto M; Kurakata S
Anticancer Drugs; 2012 Jan; 23(1):119-30. PubMed ID: 22008853
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element/MEK-ERK1/2 pathway.
Kamimura M; Viedt C; Dalpke A; Rosenfeld ME; Mackman N; Cohen DM; Blessing E; Preusch M; Weber CM; Kreuzer J; Katus HA; Bea F
Circ Res; 2005 Aug; 97(4):305-13. PubMed ID: 16037570
[TBL] [Abstract][Full Text] [Related]
19. MEK1/2 induces STAT5-mediated germline transcription of the TCRgamma locus in response to IL-7R signaling.
Maki K; Ikuta K
J Immunol; 2008 Jul; 181(1):494-502. PubMed ID: 18566415
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of MEK inhibitors on rat neural stem cell differentiation: Repressive roles of MEK2 in neurogenesis and induction of astrocytogenesis by PD98059.
Lee HR; Lee J; Kim HJ
Pharmacol Res; 2019 Nov; 149():104466. PubMed ID: 31562895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
